A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.

Research Site, Lausanne

Research Site, Goyang-si

Research Site, Marseille

Research Site, Seongnam-si

Research Site, Caen

Research Site, Philadelphia

Research Site, Dijon

Research Site, Towson

Research Site, Newnan

Research Site, Toulouse

Research Site, Bordeaux

Research Site, Hilliard

Research Site, Nantes

Research Site, Detroit

Research Site, Petah Tikva

Research Site, Clermont-Ferrand

Research Site, St Louis

Research Site, Pierre Benit Cedex

Research Site, Paris

Research Site, Jerusalem

Research Site, Haifa

Research Site, Villejuif

Research Site, Ramat Gan

Research Site, Tel Aviv

Research Site, Boston

Research Site, Amsterdam

Research Site, Amsterdam

Research Site, Maastricht

Research Site, Nijmegen

Research Site, Rotterdam

Research Site, Utrecht

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Research Site, Chur

Research Site, Cambridge

Research Site, Dundee

Research Site, Glasgow

Research Site, Greater London

Research Site, London

Research Site, London

Research Site, Manchester

Research Site, Newcastle upon Tyne

Research Site, Sutton